{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:28:29Z","timestamp":1787783309488,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["403230\/2021-7"],"award-info":[{"award-number":["403230\/2021-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.exppara.2024.108764","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T15:19:36Z","timestamp":1714058376000},"page":"108764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Oxfendazole Nitazoxanide combination in experimental neurocysticercosis \u2013 Anti-inflammatory and cysticidal effects"],"prefix":"10.1016","volume":"262","author":[{"given":"Jefferson Aber Alves","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taynara Cristina","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Cindy Neres","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngrid Batista da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy de Souza","family":"Lino Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-9191","authenticated-orcid":false,"given":"Marina Clare","family":"Vinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.exppara.2024.108764_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jsps.2021.04.004","article-title":"Anthelmintics for drug repurposing: Opportunities and challenges","volume":"29","author":"Alavi","year":"2021","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.exppara.2024.108764_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1741-7015-11-219","article-title":"Venous endothelial injury in central nervous system diseases","volume":"11","author":"Alexander","year":"2013","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.exppara.2024.108764_bib3","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1007\/s11033-022-07822-2","article-title":"Nitazoxanide and COVID-19: a review","volume":"49","author":"Al-Kuraishy","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"1438","key":"10.1016\/j.exppara.2024.108764_bib4","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1098\/rstb.2003.1358","article-title":"Inflammation in central nervous system injury","volume":"358","author":"Allan","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"4","key":"10.1016\/j.exppara.2024.108764_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02255-18","article-title":"Pharmacokinetics, safety, and Tolerability of oxfendazole in Healthy Volunteers: a Randomized, placebo-controlled first-in-human single-dose escalation study","volume":"63","author":"An","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.exppara.2024.108764_bib6","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000606","article-title":"Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis","volume":"20","author":"Anand","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"10.1016\/j.exppara.2024.108764_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1358\/dot.2021.57.7.3235211","article-title":"Role of nitazoxanide as a repurposed drug in the treatment and management of various diseases","volume":"57","author":"Bharti","year":"2021","journal-title":"Drugs Today (Barc)."},{"issue":"16","key":"10.1016\/j.exppara.2024.108764_bib8","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4155\/fmc-2016-0062","article-title":"Anti-inflammatory trends of new benzimidazole derivatives","volume":"8","author":"Bukhari","year":"2016","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.exppara.2024.108764_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1550-7408.2002.tb00523.x","article-title":"In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites","volume":"49","author":"Cedillo-Rivera","year":"2002","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.exppara.2024.108764_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106571","article-title":"Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis","volume":"234","author":"Correia","year":"2022","journal-title":"Acta Trop."},{"issue":"5","key":"10.1016\/j.exppara.2024.108764_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001500","article-title":"Neurocysticercosis: neglected but not forgotten","volume":"6","author":"Coyle","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"8","key":"10.1016\/j.exppara.2024.108764_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14787210.2020.1761332","article-title":"Current approaches to cysticidal drug therapy for neurocysticercosis","volume":"18","author":"Del Brutto","year":"2020","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.exppara.2024.108764_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.apar.2021.03.003","article-title":"Taenia solium taeniasis\/cysticercosis: from parasite biology and immunology to diagnosis and control","volume":"112","author":"Dixon","year":"2021","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.exppara.2024.108764_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/IJGM.S73249","article-title":"Managing neurocysticercosis: challenges and solutions","volume":"8","author":"Fogang","year":"2015","journal-title":"Int. J. Gen. Med."},{"issue":"9383","key":"10.1016\/j.exppara.2024.108764_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(03)14117-7","article-title":"Taenia solium cysticercosis","volume":"362","author":"Garcia","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.exppara.2024.108764_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.2011.03945.x","article-title":"Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis","volume":"72","author":"Garcia","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.exppara.2024.108764_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vetpar.2007.06.028","article-title":"Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs","volume":"148","author":"Gokbulut","year":"2007","journal-title":"Vet. Parasitol."},{"issue":"1","key":"10.1016\/j.exppara.2024.108764_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14787210.2018.1555241","article-title":"Oxfendazole: a promising agent for the treatment and control of helminth infections in humans","volume":"17","author":"Gonzalez","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"16","key":"10.1016\/j.exppara.2024.108764_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/vr.141.16.420","article-title":"Treatment of porcine cysticercosis with oxfendazole: a dose-response trial","volume":"141","author":"Gonzalez","year":"1997","journal-title":"Vet. Rec."},{"issue":"7","key":"10.1016\/j.exppara.2024.108764_bib20","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s10620-020-06193-7","article-title":"Helicobacter pylori: a review of current diagnostic and management strategies","volume":"65","author":"Guevara","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.exppara.2024.108764_bib21","first-page":"79","article-title":"Amebiasis and amebic liver abscess in children","volume":"69","author":"Gupta","year":"2022","journal-title":"Pediatr. Clin."},{"issue":"12","key":"10.1016\/j.exppara.2024.108764_bib22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1080\/14787210.2021.1912592","article-title":"Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions","volume":"19","author":"Hamamoto Filho","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"5","key":"10.1016\/j.exppara.2024.108764_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/acn3.562","article-title":"Inflammation is a key risk factor for persistent seizures in neurocysticercosis","volume":"10","author":"Herrick","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.exppara.2024.108764_bib24","article-title":"Alterations in Taenia crassiceps cysticerci cytoskeleton induced by nitazoxanide and flubendazole","volume":"221","author":"Lima","year":"2021","journal-title":"Acta Trop."},{"issue":"6","key":"10.1016\/j.exppara.2024.108764_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1590\/S0037-86822002000600012","article-title":"Caracter\u00edsticas evolutivas do Cysticercus cellulosae no enc\u00e9falo e no cora\u00e7\u00e3o","volume":"35","author":"Lino Junior","year":"2002","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"1","key":"10.1016\/j.exppara.2024.108764_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1090-0233(02)00124-7","article-title":"Morphological changes to early stage Taenia solium cysticerci following oxfendazole treatment","volume":"165","author":"Liu","year":"2003","journal-title":"Vet. J."},{"issue":"4","key":"10.1016\/j.exppara.2024.108764_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S0004-282X2012005000010","article-title":"Experimental encephalitis caused by Taenia crassiceps cysticerci in mice","volume":"70","author":"Matos-Silva","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.exppara.2024.108764_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12639-020-01228-2","article-title":"Effect of oxfendazole to control Taenia solium cysticercosis in pigs in Punjab state of India","volume":"44","author":"Megha","year":"2020","journal-title":"J. Parasit. Dis."},{"issue":"4","key":"10.1016\/j.exppara.2024.108764_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/511040","article-title":"Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis","volume":"44","author":"Mitre","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2024.108764_bib30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3389\/fmicb.2015.01208","article-title":"Drug development against the major diarrhea-causing parasites of the small intestine, Cryptosporidium and Giardia","volume":"6","author":"Miyamoto","year":"2015","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.exppara.2024.108764_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002200","article-title":"Efficacy and safety of anthelmintics tested against Taenia solium cysticercosis in pigs","volume":"7","author":"Mkupasi","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10","key":"10.1016\/j.exppara.2024.108764_bib32","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1016\/j.fct.2012.07.023","article-title":"A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles","volume":"50","author":"Moreno","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.exppara.2024.108764_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/AAC.37.2.328","article-title":"Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro","volume":"37","author":"Morgan","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.exppara.2024.108764_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S0031182015001572","article-title":"Cellular immune response in intraventricular experimental neurocysticercosis","volume":"143","author":"Moura","year":"2016","journal-title":"Parasitology"},{"issue":"8","key":"10.1016\/j.exppara.2024.108764_bib35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1586\/ern.11.86","article-title":"Corticosteroid use in neurocysticercosis","volume":"11","author":"Nash","year":"2011","journal-title":"Expert Rev. Neurother."},{"issue":"3","key":"10.1016\/j.exppara.2024.108764_bib36","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults","volume":"3","author":"Nelson","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.exppara.2024.108764_bib37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QCO.0000000000000831","article-title":"Neurocysticercosis: an update on diagnosis, treatment, and prevention","volume":"35","author":"Pineda-Reyes","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.exppara.2024.108764_bib38","article-title":"Adverse side effects of dexamethasone in surgical patients","volume":"11","author":"Polderman","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.exppara.2024.108764_bib39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1017\/S0031182020000505","article-title":"Histopathologic evaluation of experimental murine neurocysticercosis after treatment with albendazole\/nitazoxanide combination","volume":"147","author":"Sampaio","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2024.108764_bib40","article-title":"Albendazole - ivermectin combination decreases inflammation in experimental neurocysticercosis","volume":"251","author":"Santana","year":"2023","journal-title":"Exp. Parasitol."},{"issue":"1\u20132","key":"10.1016\/j.exppara.2024.108764_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.physbeh.2007.05.050","article-title":"Inflammation in the nervous system--physiological and pathophysiological aspects","volume":"92","author":"Schultzberg","year":"2007","journal-title":"Physiol. Behav."},{"issue":"1\u20132","key":"10.1016\/j.exppara.2024.108764_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vetpar.2008.08.014","article-title":"Taenia solium porcine cysticercosis: viability of cysticerci and persistency of antibodies and cysticercal antigens after treatment with oxfendazole","volume":"158","author":"Sikasunge","year":"2008","journal-title":"Vet. Parasitol."},{"issue":"1","key":"10.1016\/j.exppara.2024.108764_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2013.12.002","article-title":"Nitazoxanide: nematicidal mode of action and drug combination studies","volume":"193","author":"Somvanshi","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.exppara.2024.108764_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/AAC.47.2.467-474.2003","article-title":"In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes","volume":"47","author":"Stettler","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2024.108764_bib45","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3389\/fimmu.2018.02652","article-title":"Human extraparenchymal neurocysticercosis: the control of inflammation favors the Host\u2026but also the parasite","volume":"9","author":"Toledo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exppara.2024.108764_bib46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4269\/ajtmh.1997.57.354","article-title":"Immunoblot with cerebrospinal fluid from patients with neurocysticercosis using antigen from cysticerci of Taenia solium and Taenia crassiceps","volume":"57","author":"Vaz","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2024.108764_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105448","article-title":"Metabolic effects of anthelminthic drugs in the larval stage of the cestode Taenia crassiceps, cysticercosis experimental model - a review","volume":"206","author":"Vinaud","year":"2020","journal-title":"Acta Trop."},{"issue":"4","key":"10.1016\/j.exppara.2024.108764_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.exppara.2007.01.013","article-title":"Taenia crassiceps organic acids detected in cysticerci","volume":"116","author":"Vinaud","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.exppara.2024.108764_bib49","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4269\/ajtmh.18-88751","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the infectious diseases society of America (IDSA) and the American society of tropical medicine and hygiene (ASTMH)","volume":"98","author":"White Jr","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.exppara.2024.108764_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/14787210.2.1.43","article-title":"Nitazoxanide: a new broad spectrum antiparasitic agent","volume":"2","author":"White","year":"2004","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.exppara.2024.108764_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2023.e01895","article-title":"Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis","volume":"34","author":"Zhao","year":"2023","journal-title":"IDCases"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489424000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489424000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T22:24:27Z","timestamp":1718231067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489424000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"alternative-id":["S0014489424000675"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2024.108764","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxfendazole Nitazoxanide combination in experimental neurocysticercosis \u2013 Anti-inflammatory and cysticidal effects","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2024.108764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108764"}}